Supplier

Bristol-Myers Squibb spol. s r.o.

Value won

CZK 129.9m

Across 1 contract won

A Czech Republic supplier, with 1 awarded contract, most recently 17 months ago.

Czech Republic(inferred)

Track Bristol-Myers Squibb spol. s r.…

We'll email you when they win a contract · Free · No card

Value won

CZK 129.9m

Across 1 contract won

Contract history

1 entry

9 June 2025

17 months ago · Won · £129,879,212 · Supply of Antineoplastic Drugs Containi…

Opportunities

Showing awarded · 2

AwardedHealthcare & MedicalCzech Republic

Immunosuppressive Drugs Supply Contract

This public procurement contract involves the ongoing supply of immunosuppressive medications containing risankizumab, tofacitinib, apremilast, mirikizumab, deucravacitinib, voclosporin, and siltuximab over a period of 4 years, based on the current needs of the contracting authority. The total value

CZK 52,829,572FACULTY HOSPITAL HRADEC KRLOV

Published 26 Jun 2025

AwardedHealthcare & MedicalCzech Republic

Supply of Antineoplastic Drugs Containing Nivolumab and Relatlimab

This public procurement contract involves the ongoing supply of pharmaceutical products containing the active ingredients nivolumab and relatlimab. The contract is valued at approximately 129.9 million euros and is intended for the health sector. The buyer is the Faculty Hospital in Olomouc, Czech R

CZK 129,879,212FACULTY HOSPITAL OLOMOUC

Published 9 Jun 2025